You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune globulin subcutaneous

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immunodeficiency Diseases (PID) Trial in Japan (Immune Globulin Intravenous (IGIV), Immune Globulin Subcutaneous, 20%

Completed
  • Primary Immunodeficiency Diseases (PID)
  • Immune Globulin Intravenous (IGIV)
  • Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%)
  • Nagoya-shi, Aichi, Japan
  • +7 more
Feb 23, 2022

Primary Immunodeficiency Diseases (PID) Trial (TAK-881, HYQVIA)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • TAK-881
  • HYQVIA
  • (no location specified)
Feb 23, 2023

Primary Immunodeficiency Diseases (PID) Trial (TAK-881)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • TAK-881
  • (no location specified)
Oct 4, 2023

COPD Exacerbation Acute Trial in Rochester (CUVITRU - Ig subcutaneous human 20%, Standard Medical Therapy)

Not yet recruiting
  • COPD Exacerbation Acute
  • CUVITRU - Ig subcutaneous human 20%
  • Standard Medical Therapy
  • Rochester, New York
  • +2 more
Feb 28, 2023

Healthy Volunteers Trial in Hialeah (TAK-881)

Completed
  • Healthy Volunteers
  • TAK-881
  • Hialeah, Florida
    Clinical Pharmacology of Miami
Apr 28, 2022

CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy Trial in New Brunswick (Intravenous immune

Recruiting
  • CIDP
  • +2 more
  • Intravenous immune globulin G
  • Subcutaneous immune globulin G
  • New Brunswick, New Jersey
    Rutgers, The State University of New Jersey Clinical Research Ce
Oct 13, 2022

Chronic Inflammatory Demyelinating Polyneuropathy Trial in Tampa (Immune Globulin Subcutaneous (Human))

Completed
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Immune Globulin Subcutaneous (Human)
  • Tampa, Florida
    USF Dept of Neurology
Sep 14, 2021

Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia Trial in Columbus, Pittsburgh (Xembify,

Recruiting
  • Hypogammaglobulinemia
  • +2 more
  • Columbus, Ohio
  • +1 more
Jan 16, 2023

Primary Immunodeficiency Trial in United States (IGSC 20%)

Completed
  • Primary Immunodeficiency
  • IGSC 20%
  • Birmingham, Alabama
  • +11 more
Nov 2, 2022

Primary Immunodeficiency Diseases (PID) Trial in Worldwide (Immune Globulin Subcutaneous (Human), 20%, Immune Globulin

Completed
  • Primary Immunodeficiency Diseases (PID)
  • Immune Globulin Subcutaneous (Human), 20%
  • +2 more
  • Vienna, Austria
  • +11 more
Apr 30, 2021

Myasthenia Gravis Trial in Canada, United States (HIZENTRA ®)

Completed
Has Results
  • Myasthenia Gravis
  • HIZENTRA ®
  • Phoenix, Arizona
  • +4 more
May 9, 2021

Primary Immunodeficiency Diseases (PID) Trial in United States (SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC,

Completed
Has Results
  • Primary Immunodeficiency Diseases (PID)
  • SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC, 10% only (safety)
  • +2 more
  • Cypress, California
  • +10 more
Apr 30, 2021

Primary Immunodeficiency Diseases (PID) Trial in Canada, United States (Immune Globulin Intravenous (Human), 10% Solution,

Completed
Has Results
  • Primary Immunodeficiency Diseases (PID)
  • Immune Globulin Intravenous (Human), 10% Solution
  • Immune Globulin Subcutaneous (Human), 20% Solution
  • Irvine, California
  • +17 more
Jun 30, 2021

Real-world CANadian CUvitru Non-Interventional Study in Subjects

Completed
  • Primary Immunodeficiency Diseases (PID)
  • CUVITRU
  • Hamilton, Ontario, Canada
  • +2 more
Mar 3, 2021

Primary Immunodeficiency Diseases (PID) Trial in United States (Immune Globulin Intravenous (Human), 10%)

Completed
Has Results
  • Primary Immunodeficiency Diseases (PID)
  • Immune Globulin Intravenous (Human), 10%
  • Los Angeles, California
  • +8 more
Apr 29, 2021

Conducted in Poland to Document Management and Clinical Outcome

Completed
  • Primary Immunodeficiencies (PID)
    • Gdańsk, Poland
    • +4 more
    Nov 15, 2021

    Primary Immunodeficiency Diseases (PID) Trial in United States (Immune Globulin Infusion (Human), 10%, Recombinant human

    Completed
    Has Results
    • Primary Immunodeficiency Diseases (PID)
    • Immune Globulin Infusion (Human), 10%
    • Recombinant human hyaluronidase
    • Irvine, California
    • +9 more
    Apr 30, 2021

    Survey of Human Rabies Immune Globulin Safety in Children

    Recruiting
    • Rabies
    • +3 more
    • Human rabies immune globulin 300 IU/mL
    • Houston, Texas
      Houston Methodist
    Aug 22, 2022

    Immunologic Deficiency Syndromes Trial in Canada, United States (GC5107)

    Completed
    Has Results
    • Immunologic Deficiency Syndromes
    • GC5107
    • Centennial, Colorado
    • +19 more
    Nov 11, 2022

    Chronic Hepatitis B Trial run by the NIDDK (hepatitis B immune globulin (HBIg), Pegylated interferon alfa (pegIFN))

    Withdrawn
    • Chronic Hepatitis B
    • hepatitis B immune globulin (HBIg)
    • Pegylated interferon alfa (pegIFN)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 4, 2022

    Rabies Trial in Philippines, United States (SYN023, HRIG (HyperRab), Rabies vaccine)

    Completed
    • Rabies
    • SYN023
    • +2 more
    • Gainesville, Florida
    • +13 more
    Sep 29, 2022

    Primary Immunodeficiency Disease Trial in Japan (IGSC 20% infusion)

    Active, not recruiting
    • Primary Immunodeficiency Disease
    • IGSC 20% infusion
    • Nagoya, Aichi, Japan
    • +7 more
    Jan 4, 2023

    Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)

    Recruiting
    • Primary Immune Thrombocytopenia
    • STSA-1301 subcutaneous injection
    • Placebo
    • Beijing, Chaoyang District, China
      Beijing Ditan Hospital,Capital Medical University
    Nov 28, 2023

    Hepatitis A Trial in Almaty (Hepatitis A vaccine)

    Completed
    • Hepatitis A
    • Hepatitis A vaccine
    • Almaty, Kazakhstan
      Sanitary EpidemiologyAuthority
    Dec 27, 2021

    De Novo Kidney Transplant Patients Trial in China (ATG-F)

    Completed
    • De Novo Kidney Transplant Patients
    • Beijing, China
    • +13 more
    Jul 26, 2022